Brain natriuretic peptide (BNP) is a member oi the natriuretic peptide
family. The effects of intracerebroventricularly administered BNP (in
0.002-200 ng doses) on the analgesic, tolerance-inducing and dependen
ce-inducing actions of morphine were investigated in adult male CFLP m
ice. Graded doses of BNP centrally did not affect pain sensitivity its
elf in a fail-flick test. However, different doses ai BNP depressed th
e acute nociceptive effect of a single subcutaneous dose of morphine (
5 mg/kg), and BNP attenuated the development of acute and chronic tole
rance to morphine. Withdrawal signs were studied by injecting naloxone
(1 mg/kg s.c.), There was no significant difference in symptoms betwe
en the tolerant group and animals treated with BNP. The data obtained
indicate that BNP can modify the analgesic action of morphine.